Other substances

Dobutamine

A beta-1 adrenoreceptor agonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

2
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Dobutamine on PubChem

Marketed as

DOBUJECT; DOBUSAFE; DOBUTAMIN; DOBUTAMINE; DOBUTAN; DOBUTEL; DOBUTIL; DOPMIN; INOTREX

 

Structure image - Dobutamine

CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
3CLpro Small molecule In silico 		in silico 2.46

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Oct/13/2020
Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
PapainLpro Small molecule In silico 		in silico 3.43

Predicted to inhibit SARS-CoV-2 Papain-like protease.

 Feb/24/2021

AI-suggested references

Link Publication date
Fenoterol and dobutamine as COVID-19 main protease inhibitors: A virtual screening study
Oct/13/2020
Export (.csv)